Patheon (Thermo Fisher Scientific EU Sites)
Ferentino, Italy (EU operations HQ; corporate HQ: Waltham, MA)
2 confirmed programs
· 2 sponsors
—
Not Assessed
✓ FDA Inspections (1)
✓ Clinical Trials (2)
✓ SEC Filings (14)
✓ Press (20)
✓ EMA GMP (1)
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2024-11-20)
EMA GMP Certificates1 on record
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 2 partnership announcements found in press monitoring.
Programs
2
Sponsors2
ModalitiesOral Solid Dose, Sterile Injectables, Softgels, HPAPI/Oncology, Lyophilization, Biologics FDF, Controlled Substances
2 active programs across 2 sponsors
Modalities: HPAPI/Oncology, Lyophilization, Sterile Injectables, Oral Solid Dose, Biologics FDF, Controlled Substances, Softgels
2 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
Partnership Announcements (from press monitoring)
Source: ClinicalTrials.gov · Retrieved Mar 26, 2026
Financial Stability
—
Insufficient financial data. Score requires company profile or SEC filings.
SEC Filings14 with industry mentions
Private company
Financial assessment: 60.0/100
Capacity
—
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press20 articles
Broad modality coverage (7 modalities)
FDA Inspection History
2024-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-11-20 | Saint Louis, Missouri | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Mar 26, 2026
EMA GMP Compliance 1 certificates
2025-11
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| CRN00GTCX/ASR12633 | Thermo Fisher Scientific Cork Limited | Ireland | 2025-11-07 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Mar 26, 2026
Clinical Activity 2 studies
NCT02340936
Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide...
PHASE1/PHASE2
Completed
NCT00982111
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell...
PHASE3
Completed
Source: ClinicalTrials.gov · Retrieved Mar 26, 2026
Financial Intelligence
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
Source: SEC EDGAR · Retrieved Mar 26, 2026
Recent News 20 articles
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions - Business Wire
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions Business Wire
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio - pharmiweb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio pharmiweb.com
Thermo Fisher, SHL Medical collab on drug delivery device production - Drug Delivery Business
Thermo Fisher, SHL Medical collab on drug delivery device production Drug Delivery Business
Thermo Fisher Scientific supports Swindon with place-marketing campaign - Rayo
Thermo Fisher Scientific supports Swindon with place-marketing campaign Rayo
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates - Bitget
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates Bitget
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates - Bitget
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates Bitget
Where is Trump going in Cincinnati? What to know about the 2 locations - Cincinnati Enquirer
Where is Trump going in Cincinnati? What to know about the 2 locations Cincinnati Enquirer
EXCLUSIVE: President Donald Trump speaks 1-on-1 with Local 12 during Cincinnati visit - The National News Desk
EXCLUSIVE: President Donald Trump speaks 1-on-1 with Local 12 during Cincinnati visit The National News Desk
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing - GuruFocus
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing GuruFocus
What to know about the businesses Trump is visiting in Cincinnati - Cincinnati Enquirer
What to know about the businesses Trump is visiting in Cincinnati Cincinnati Enquirer
FDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection - Fierce Biotech
FDA reconsidering Capricor’s snubbed DMD cell therapy after 'lifting' rejection Fierce Biotech
Thermo Fisher Scientific opens new distribution centre in Meath - Silicon Republic
Thermo Fisher Scientific opens new distribution centre in Meath Silicon Republic
Pharmaceutical CDMO Market Set for Strong Growth to USD 293.6 - openPR.com
Pharmaceutical CDMO Market Set for Strong Growth to USD 293.6 openPR.com
Thermo Fisher Scientific opens new distribution centre in Ireland - Med-Tech Insights
Thermo Fisher Scientific opens new distribution centre in Ireland Med-Tech Insights
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC - R&D World
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC R&D World
Lithuania’s manufacturing shift: Teltonika, Thermo Fisher & Orlen lead high-tech growth - LRT
Lithuania’s manufacturing shift: Teltonika, Thermo Fisher & Orlen lead high-tech growth LRT
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance UK
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More Yahoo Finance UK
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy - Pharmaceutical Online
Activate Advanced Contamination Control Technology To Safeguard Your Cell Therapy Pharmaceutical Online
Hot-Melt Extrusion and Downstream Processing - News-Medical
Hot-Melt Extrusion and Downstream Processing News-Medical
Represent this organization? Contact us to verify or update this profile.